Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Most Undervalued Dow Stocks to Buy Now

In this article, we will be taking a look at the 5 Most Undervalued Dow Stocks to Buy Now. If you wish to see the full list, visit 10 Most Undervalued Dow Stocks to Buy Now.

5. International Business Machines Corporation (NYSE:IBM)

International Business Machines Corporation (NYSE:IBM) is among the most undervalued Dow stocks on this list.

TheFly reported on April 20 that Jefferies reduced its price target on IBM from $370 to $320 while maintaining a Buy rating. The firm highlighted expectations for a strong first-quarter performance, anticipating that IBM could exceed Street estimates driven by approximately 11% year-over-year software growth supported by easier comparison metrics.

Separately, earlier on April 10, the U.S. Department of Justice announced a False Claims Act settlement with International Business Machines Corporation (NYSE:IBM) totaling $17,077,043, including civil penalties. The resolution addresses allegations that the company did not meet anti-discrimination obligations tied to its federal contracts. Authorities stated the case involved practices that were alleged to have resulted in discrimination against employees and job applicants based on race, color, national origin, or sex.

The settlement marks the first resolution under a Civil Rights Fraud Initiative launched in May 2025. Officials emphasized that compliance with equal employment requirements remains a condition for companies holding federal contracts. IBM did not admit liability as part of the agreement, and the payment resolves the government’s claims under the False Claims Act related to workplace and hiring practices under federal contracting rules.

International Business Machines Corporation (NYSE:IBM) is a global technology company founded in 1911 and based in New York. It specializes in hybrid cloud, AI, consulting, and quantum computing, serving clients across industries like finance, healthcare, and telecom.

4. Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (NYSE:MRK) is among the most undervalued stocks.

On April 20, MRK announced that the U.S. Food and Drug Administration granted Priority Review to two supplemental Biologics License Applications for KEYTRUDA and KEYTRUDA QLEX, each used in combination with Padcev for patients with muscle-invasive bladder cancer who are eligible for cisplatin-based chemotherapy.

The FDA assigned a target action date of August 17, 2026. The applications are supported by Phase 3 KEYNOTE-B15 data evaluating perioperative treatment with surgery compared to standard chemotherapy. Results from the program showed improved outcomes, including survival benefits, across multiple bladder cancer studies. The combination is already approved in several regions for advanced urothelial cancer and is being further studied across earlier and later stages of bladder disease.

Separately, it was reported on April 7 that on March 25, Merck & Co., Inc. (NYSE:MRK) announced the initiation of a cash tender offer, through a subsidiary, to acquire all outstanding shares of Terns Pharmaceuticals at $53.00 per share in cash. The offer follows a previously disclosed definitive agreement between the companies. If completed, Terns would become a wholly owned subsidiary of Merck.

The transaction requires more than 50% of shares to be tendered, regulatory clearance under antitrust rules, and other customary closing conditions. The offer is set to expire on May 4, 2026, unless extended. Merck has filed formal tender documentation with the SEC, and Terns’ board has recommended that shareholders accept the offer and tender their shares. The deal is expected to close in the second quarter of 2026.

Merck & Co., Inc. (NYSE:MRK) is a global pharmaceutical company founded in 1891 and based in Rahway, New Jersey. It develops medicines, vaccines, and biologic therapies, and is a leader in oncology and infectious disease treatments.

3. The Procter & Gamble Company (NYSE:PG)

The Procter & Gamble Company (NYSE:PG) is also one of the most undervalued Dow stocks on this list.

TheFly reported on April 10 that BofA Securities reduced its price target on PG from $171 to $167 while maintaining a Buy rating. The firm kept its third-quarter earnings-per-share estimate at $1.55 but lowered its fiscal 2026 and 2027 projections, citing higher expected resin costs.

In a significant move, on April 14, The Procter & Gamble Company (NYSE:PG) announced that its Board of Directors approved an increased quarterly dividend of $1.0885 per share on common stock as well as on its Series A and Series B ESOP Convertible Class A Preferred Stock. The new payout reflects a 3% rise compared to the previous quarter. The dividend will be paid on or after May 15, 2026, to shareholders of record as of April 24, 2026.

The increase applies to both common and eligible preferred shareholders. This adjustment continues the company’s long-standing practice of regular dividend growth. The decision underscores P&G’s ongoing commitment to returning capital to shareholders through consistent income distribution while maintaining its established dividend policy across all share classes.

The Procter & Gamble Company (NYSE:PG) is a global consumer goods company founded in 1837 and based in Cincinnati, Ohio. It produces widely used household and personal care brands such as Tide, Pampers, Gillette, and Crest, operating in about 70 countries.

2. The Walt Disney Company (NYSE:DIS)

The Walt Disney Company (NYSE:DIS) is among the most undervalued stocks on this list.

TheFly reported on April 8 that Barclays revised its outlook on DIS, reducing its price target to $130 from $140 while maintaining an Overweight rating on the stock. The adjustment was made during a broader review of media sector estimates ahead of first-quarter earnings expectations. The firm highlighted that the industry continues to face both company-specific and broader cyclical pressures, which may encourage investors to remain cautious and favor higher-quality names even when valuations appear attractive. This update reflects a reassessment of near-term earnings visibility across the sector and a more conservative stance on growth expectations in the current market environment.

In another recent movement, on April 16, The Walt Disney Company (NYSE:DIS) has reportedly communicated to advertisers that it expects pricing of around $10 million for a 30-second commercial during its upcoming Super Bowl broadcast in 2027, according to industry sources cited in reporting. The game will mark Disney’s return as a Super Bowl broadcaster after a long gap of about two decades.

However, the proposed pricing has been met with hesitation from some marketers, who view the figure as high compared with recent market dynamics. Reports indicate that competing broadcasters have typically secured a large portion of Super Bowl advertising inventory well before the formal upfront selling season, while Disney’s current sales progress appears more limited at this stage.

The Walt Disney Company (NYSE:DIS) is a global entertainment company founded in 1923 and based in Burbank, California. It operates through Disney Entertainment, ESPN, and Disney Experiences, with major brands including Disney, Pixar, Marvel, and Star Wars.

1. Salesforce, Inc. (NYSE:CRM)

Salesforce, Inc. (NYSE:CRM) tops our list of most undervalued stocks.

TheFly reported on April 17 that Piper Sandler revised its outlook on CRM, reducing its price target from $250 to $215 while maintaining an Overweight rating. The firm cited a difficult environment for enterprise software in 2026, noting that advanced AI model developers are increasingly expanding into higher layers of business software and competing more directly for corporate IT spending. It also pointed to growing pressure on valuation assumptions as investors rethink long-term earnings multiples. Ahead of the upcoming first-quarter results, the firm adjusted group-level multiples and also downgraded three companies within the sector.

Separately, on April 15, Salesforce, Inc. (NYSE:CRM) announced an expanded partnership with Engine, a global travel connectivity platform. As part of the agreement, Engine will use CRM’s Agentforce 360 Platform to support its goal of improving connectivity and efficiency in the travel sector. The collaboration also integrates Slack alongside Agentforce to create a unified digital workspace. This setup is designed to allow employees and AI agents to operate together in real time, improving coordination across travel-related processes. Engine stated that the combined system will function as a central command hub to streamline and enhance each stage of the travel experience for users and operators.

Salesforce, Inc. (NYSE:CRM) is a global leader in cloud-based CRM software, founded in 1999 and based in San Francisco. It provides tools for sales, service, marketing, and analytics, and focuses on AI-driven customer solutions through its Einstein and Agentforce platforms.

While we acknowledge the risk and potential of CRM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CRM and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Mid Cap Stocks to Invest In According to Billionaires and 10 Best Cheap Stocks Under $10 to Buy in April.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.